Taro Pharmaceutical ( TARO) is a recommended buy with a price target of $175. The Company markets over 200 generic pharmaceutical products in over 25 countries and is largely known for its dominating ...

What could be wrong with 5 years of double digit growth with no end in sight? Well, someone else wants it more than you and has a history of not paying full price. Taro is Israeli generic and branded ...

Taro Pharmaceutical was one of the rare exceptions of a stock that advanced while the S&P 500 descended into a bear market.

Taro Pharmaceutical (TARO) has released an update. Taro Pharmaceutical Industries Ltd. shareholders have endorsed a merger with Sun Pharmaceutical Industries, a move that is expected to enhance global ...

Indian richest man seized control of Taro when its founders gave up hope and turned it around successfully by increasing sales & research. The industry is facing strong pricing pressures in the new ...

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (“Sun Pharma”) and Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced today that ...

Even as public outrage over dramatic price increases on generic drugs is growing, a federal antitrust investigation is heating up. Grand jury subpoenas have been sent ...

MUMBAI, May 21 (Reuters) - India's Sun Pharma said it has agreed to buy Israeli generic drug maker Taro for $454 million to help boost its sales in markets such as the United States, sending its ...

AUSTIN (CN) - Taro Pharmaceuticals will pay $19.5 million to settle a Medicaid fraud investigation, the Texas attorney general said. The civil investigation alleged the Hawthorne, N.Y.-based company ...

WASHINGTON (Reuters) - Taro Pharmaceutical agreed to pay more than $200 million to settle allegations that it conspired to fix the prices of generic drugs, the Justice Department said on Thursday. The ...

Taro saw rising revenue in the fourth quarter but falling net income. Sun Pharmaceutical already owns 78.5% of Taro's shares. SunPharma is India's largest drugmaker. Sun Pharmaceuticals already owns ...

Department of Justice investigators have subpoenaed Taro Pharmaceutical Industries (TARO) and two senior officers, seeking documents related to generic-drug pricing and sales. The Israel-based company ...